mTOR/p70S6K signaling distinguishes routine, maintenance-level autophagy from autophagic cell death during influenza A infection

Abstract Autophagy, a stress response activated in influenza A virus infection helps the cell avoid apoptosis. However, in the absence of apoptosis infected cells undergo vastly expanded autophagy and nevertheless die in the presence of necrostatin but not of autophagy inhibitors. Combinations of in...

Full description

Saved in:
Bibliographic Details
Published inVirology (New York, N.Y.) Vol. 452; pp. 175 - 190
Main Authors Datan, Emmanuel, Shirazian, Alireza, Benjamin, Shawna, Matassov, Demetrius, Tinari, Antonella, Malorni, Walter, Lockshin, Richard A, Garcia-Sastre, Adolfo, Zakeri, Zahra
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.03.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Autophagy, a stress response activated in influenza A virus infection helps the cell avoid apoptosis. However, in the absence of apoptosis infected cells undergo vastly expanded autophagy and nevertheless die in the presence of necrostatin but not of autophagy inhibitors. Combinations of inhibitors indicate that the controls of protective and lethal autophagy are different. Infection that triggers apoptosis also triggers canonical autophagy signaling exhibiting transient PI3K and mTORC1 activity. In terminal autophagy phospho-mTOR(Ser2448) is suppressed while mTORC1, PI3K and mTORC2 activities increase. mTORC1 substrate p70S6K becomes highly phosphorylated while its activity, now regulated by mTORC2, is required for LC3-II formation. Inhibition of mTORC2/p70S6K, unlike that of PI3K/mTORC1, blocks expanded autophagy in the absence of apoptosis but not moderate autophagy. Inhibitors of expanded autophagy limit virus reproduction. Thus expanded, lethal autophagy is activated by a signaling mechanism different from autophagy that helps cells survive toxic or stressful episodes.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Present address: Division of Vaccine Vectors, Profectus BioSciences, Tarrytown, NY 10591, USA.
ISSN:0042-6822
1096-0341
DOI:10.1016/j.virol.2014.01.008